Compared to healthy control subjects, a higher level and rate of re-establishment of the extracellular PF4 has been demonstrated in several patient populations, including those with diabetes [56,57], atherosclerosis [58] renal, [44] cardiovascular or coronary artery disease [59-61]. This evidence concerns the gene PF4 and diabetes mellitus.